↓ Skip to main content

Recent advances and novel agents for gastrointestinal stromal tumor (GIST)

Overview of attention for article published in Journal of Hematology & Oncology, May 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent
2 patents
facebook
1 Facebook page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
Published in
Journal of Hematology & Oncology, May 2012
DOI 10.1186/1756-8722-5-21
Pubmed ID
Authors

Gurpreet Lamba, Samir Ambrale, Byung Lee, Ridhi Gupta, Shamudheen M Rafiyath, Delong Liu

Abstract

The discovery of CD117 mutation in almost all gastrointestinal stromal tumors (GISTs) marked a milestone. Other spindle cell neoplasms arising from the GI tract including lipoma, schwannoma, hemangioma, leiomyoma, and leiomyosarcoma are typically CD117-negative. GIST research and clinical care now represent a paradigm of translating discoveries in the molecular pathogenesis of cancer into highly effective targeted therapies that selectively inhibit etiologic "driver" pathways, leading to dramatically improved clinical outcomes. A series of investigations and trials are underway to develop novel and effective ways to treat patients with GIST. In this review, we discuss the highlights of recent advances and novel agents for GIST therapy.

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Hong Kong 1 3%
Honduras 1 3%
Luxembourg 1 3%
Brazil 1 3%
Unknown 27 87%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 23%
Student > Bachelor 6 19%
Student > Doctoral Student 4 13%
Other 4 13%
Student > Master 3 10%
Other 7 23%
Readers by discipline Count As %
Medicine and Dentistry 18 58%
Agricultural and Biological Sciences 7 23%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 1 3%
Unspecified 1 3%
Other 2 6%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2013.
All research outputs
#2,487,001
of 9,633,164 outputs
Outputs from Journal of Hematology & Oncology
#100
of 466 outputs
Outputs of similar age
#25,481
of 101,753 outputs
Outputs of similar age from Journal of Hematology & Oncology
#3
of 7 outputs
Altmetric has tracked 9,633,164 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 466 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 101,753 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.